Expression of pro-angiogenic factors in malignant melanoma and their regulation by low-dose interferon-α

被引：0
|
作者：
M. Go
J. Biber
G. B. Lesinski
W. E. Carson
机构：
[1] Surgery,
[2] The Ohio State University,undefined
来源：
Annals of Surgical Oncology | 2004年 / 11卷
关键词：
Melanoma; Vascular Endothelial Growth Factor; Sentinel Node Biopsy; Vascular Endothelial Growth Factor Level; Human Melanoma Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S122 / S122
相关论文
共 50 条
  • [21] Breast Adipocyte Co-culture Increases the Expression of Pro-angiogenic Factors in Macrophages
    Yadav, Nalini V. S.
    Barcikowski, Arthur
    Uehana, Yuko
    Jacobs, Aaron T.
    Connelly, Linda
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [22] Interferon-β therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells
    Hitomi Kubo
    Atsuko Ashida
    Kazuhiko Matsumoto
    Toshiro Kageshita
    Akifumi Yamamoto
    Toshiaki Saida
    Archives of Dermatological Research, 2008, 300 : 297 - 301
  • [23] Interferon-β therapy for malignant melanoma:: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells
    Kubo, Hitomi
    Ashida, Atsuko
    Matsumoto, Kazuhiko
    Kageshita, Toshiro
    Yamamoto, Akifumi
    Saida, Toshiaki
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2008, 300 (06) : 297 - 301
  • [24] Low-dose IFN-γ induces tumor MHC expression in metastatic malignant melanoma
    Propper, DJ
    Chao, D
    Braybrooke, JP
    Bahl, P
    Thavasu, P
    Balkwill, F
    Turley, H
    Dobbs, N
    Gatter, K
    Talbot, DC
    Harris, AL
    Ganesan, TS
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 84 - 92
  • [25] MALIGNANT-MELANOMA OF THE TONGUE FOLLOWING LOW-DOSE RADIATION
    KALEMERIS, GC
    ROSENFELD, L
    GRAY, GF
    GLICK, AD
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1985, 109 (03) : 290 - 291
  • [26] Adjuvant interferon therapy for melanoma: High-dose, low-dose, no dose, which dose?
    Schuchter, LM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 7 - 10
  • [27] Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells
    Albertin, Giovanna
    Guidolin, Diego
    Sorato, Elisa
    Oselladore, Barbara
    Tortorella, Cinzia
    Ribatti, Domenico
    REGULATORY PEPTIDES, 2011, 172 (1-3) : 16 - 22
  • [28] PHASE-II STUDY OF LOW-DOSE RECOMBINANT LEUKOCYTE-A INTERFERON IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    GREEN, SJ
    LONG, HJ
    FRYTAK, S
    OFALLON, JR
    ITRI, LM
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) : 1002 - 1005
  • [29] SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS ALPHA-INTERFERON IN ADVANCED MALIGNANT-MELANOMA
    DEBRAUD, F
    BIGANZOLI, L
    BAJETTA, E
    COLLEONI, M
    ZAMPINO, MG
    TUMORI, 1993, 79 (03) : 187 - 190
  • [30] A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma
    Guillot, B
    Blazquez, L
    Bessis, D
    Dereure, O
    Guilhou, JJ
    DERMATOLOGY, 2004, 208 (01) : 49 - 54
12345